These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 39206892)
1. High Glycolytic Activity Signature Reveals CCNB2 as a Key Therapeutic Target in Triple-Negative Breast Cancer. Liang J; Ma H; Zhang S; Dong Y; Zheng J; Zeng L; Xiong X; Huang W; Yin Q; Zheng X Front Biosci (Landmark Ed); 2024 Aug; 29(8):308. PubMed ID: 39206892 [TBL] [Abstract][Full Text] [Related]
2. Cyclin B2 (CCNB2) Stimulates the Proliferation of Triple-Negative Breast Cancer (TNBC) Cells Wu S; Su R; Jia H Dis Markers; 2021; 2021():5511041. PubMed ID: 34354775 [TBL] [Abstract][Full Text] [Related]
3. Revealing Cellular Heterogeneity and Key Regulatory Factors of Triple-Negative Breast Cancer through Single-Cell RNA Sequencing. Zhang H; Sun Y; Du X Front Biosci (Landmark Ed); 2024 Aug; 29(8):290. PubMed ID: 39206896 [TBL] [Abstract][Full Text] [Related]
4. A combined hypoxia and immune gene signature for predicting survival and risk stratification in triple-negative breast cancer. Yang X; Weng X; Yang Y; Zhang M; Xiu Y; Peng W; Liao X; Xu M; Sun Y; Liu X Aging (Albany NY); 2021 Aug; 13(15):19486-19509. PubMed ID: 34341184 [TBL] [Abstract][Full Text] [Related]
5. Comprehensive scRNA-seq analysis to identify new markers of M2 macrophages for predicting the prognosis of prostate cancer. Ou Y; Xia C; Ye C; Liu M; Jiang H; Zhu Y; Yang D Ann Med; 2024 Dec; 56(1):2398195. PubMed ID: 39221762 [TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of a Glycolytic Signature and Its Regulation by Y-Box-Binding Protein 1 in Triple-Negative Breast Cancer. Lai YW; Hsu WJ; Lee WY; Chen CH; Tsai YH; Dai JZ; Yang CC; Lin CW Cells; 2021 Jul; 10(8):. PubMed ID: 34440660 [TBL] [Abstract][Full Text] [Related]
7. Integrated machine learning algorithms identify KIF15 as a potential prognostic biomarker and correlated with stemness in triple-negative breast cancer. Guo Q; Qiu P; Pan K; Liang H; Liu Z; Lin J Sci Rep; 2024 Sep; 14(1):21449. PubMed ID: 39271768 [TBL] [Abstract][Full Text] [Related]
8. Identification of an immune cell infiltration-related gene signature for prognosis prediction in triple-negative breast cancer. Wang Y; Zhang N; Zhang B; Chen Y Cell Mol Biol (Noisy-le-grand); 2024 Oct; 70(9):91-98. PubMed ID: 39380273 [TBL] [Abstract][Full Text] [Related]
9. Potential Prognostic Predictors and Molecular Targets for Skin Melanoma Screened by Weighted Gene Co-expression Network Analysis. Chen S; Liu Z; Li M; Huang Y; Wang M; Zeng W; Wei W; Zhang C; Gong Y; Guo L Curr Gene Ther; 2020; 20(1):5-14. PubMed ID: 32416689 [TBL] [Abstract][Full Text] [Related]
10. Comprehensive Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B Front Immunol; 2022; 13():931906. PubMed ID: 35958598 [TBL] [Abstract][Full Text] [Related]
11. Cyclin B2 Overexpression in Human Hepatocellular Carcinoma is Associated with Poor Prognosis. Li R; Jiang X; Zhang Y; Wang S; Chen X; Yu X; Ma J; Huang X Arch Med Res; 2019 Jan; 50(1):10-17. PubMed ID: 31101236 [TBL] [Abstract][Full Text] [Related]
12. Comprehensive characterization of stemness-related lncRNAs in triple-negative breast cancer identified a novel prognostic signature related to treatment outcomes, immune landscape analysis and therapeutic guidance: a silico analysis with in vivo experiments. Zhang M; Zhang F; Wang J; Liang Q; Zhou W; Liu J J Transl Med; 2024 May; 22(1):423. PubMed ID: 38704606 [TBL] [Abstract][Full Text] [Related]
13. Coexpression Network Analysis of Genes Related to the Characteristics of Tumor Stemness in Triple-Negative Breast Cancer. Suo HD; Tao Z; Zhang L; Jin ZN; Li XY; Ma W; Wang Z; Qiu Y; Jin F; Chen B; Cao Y Biomed Res Int; 2020; 2020():7575862. PubMed ID: 32766313 [TBL] [Abstract][Full Text] [Related]
14. CCNB2 is a novel prognostic factor and a potential therapeutic target in low-grade glioma. Wang D; Sun H; Li X; Wang G; Yan G; Ren H; Hou B Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34908101 [TBL] [Abstract][Full Text] [Related]
15. Identification of Seven Cell Cycle-Related Genes with Unfavorable Prognosis and Construction of their TF-miRNA-mRNA regulatory network in Breast Cancer. Hong Z; Wang Q; Hong C; Liu M; Qiu P; Lin R; Lin X; Chen F; Li Q; Liu L; Wang C; Chen D J Cancer; 2021; 12(3):740-753. PubMed ID: 33403032 [TBL] [Abstract][Full Text] [Related]
16. Identification of prognostic genes for early basal-like breast cancer with weighted gene co-expression network analysis. Yuan K; Wu M; Lyu S; Li Y Medicine (Baltimore); 2022 Oct; 101(42):e30581. PubMed ID: 36281185 [TBL] [Abstract][Full Text] [Related]
17. Novel biomarkers identified in triple-negative breast cancer through RNA-sequencing. Chen YL; Wang K; Xie F; Zhuo ZL; Liu C; Yang Y; Wang S; Zhao XT Clin Chim Acta; 2022 Jun; 531():302-308. PubMed ID: 35504321 [TBL] [Abstract][Full Text] [Related]
18. Identification and Validation of a Novel Glycolysis-Related Gene Signature for Predicting the Prognosis and Therapeutic Response in Triple-Negative Breast Cancer. Zheng J; Zhang YF; Han GH; Fan MY; Du MH; Zhang GC; Zhang B; Qiao J; Zhang SX; Cao JM Adv Ther; 2023 Jan; 40(1):310-330. PubMed ID: 36316558 [TBL] [Abstract][Full Text] [Related]
19. Research and experimental verification on the mechanisms of cellular senescence in triple-negative breast cancer. Cao T; Huang M; Huang X; Tang T PeerJ; 2024; 12():e16935. PubMed ID: 38435998 [TBL] [Abstract][Full Text] [Related]
20. Hsa-mir-3163 and CCNB1 may be potential biomarkers and therapeutic targets for androgen receptor positive triple-negative breast cancer. Qiu P; Guo Q; Yao Q; Chen J; Lin J PLoS One; 2021; 16(11):e0254283. PubMed ID: 34797837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]